Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UNIPROT:P04626 (
erbB-2
)
5,251
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
PC-cell-derived growth factor (
PCDGF
, progranulin) is a novel autocrine growth factor that is overexpressed in human breast cancer cell lines. We have examined immunohistochemical
PCDGF
expression in 206 paraffin-embedded human breast lesions and investigated its association with clinicopathological variables.
PCDGF
staining was observed in breast carcinoma, whereas it was almost always negative in benign breast epithelium.
PCDGF
expression was more common in invasive ductal carcinoma (80% cases positive) than in invasive lobular carcinoma (53% positive).
PCDGF
staining was almost never observed in lobular carcinoma in situ. Ductal carcinoma in situ expressed
PCDGF
in 66% of the cases, and this expression correlated strongly with nuclear grade. Similar correlation was observed between
PCDGF
expression and histologic grade of invasive ductal carcinoma. Average Ki-67 index of
PCDGF
-negative/weakly positive invasive carcinomas (30.3) was significantly lower than that of strongly
PCDGF
-positive tumors (48.8, P=0.01). A larger percentage of tumors that expressed
PCDGF
with a staining intensity of 2+ or 3+ were p53 positive (44%) than were
PCDGF
-negative tumors (25%), P=0.02.
PCDGF
expression was independent of c-
erbB-2
overexpression and of ER and PR status. Our study provides the first evidence of high incidence of
PCDGF
expression in human breast cancer in which it correlates with clinicopathological variables such as tumor grade, proliferation index, and p53 expression. These characteristics, as well as the virtual absence of expression in benign breast tissue, suggest an important role of
PCDGF
in breast cancer pathogenesis and make it a potential novel target for the treatment of breast cancer.
...
PMID:Expression of PC-cell-derived growth factor in benign and malignant human breast epithelium. 1465 16